MASAA Innovation Pvt. Ltd., operating under the brand AMSAACARE, is a science-driven Indian innovation company committed to improving human health, hygiene, and quality of life through advanced chemistry and biomedical research. Incorporated on 21st April 2021, the company represents a rare convergence of deep scientific research, patented technologies, and practical FMCG and pharmaceutical solutions.
Founded by Professor Amitava Mazumder, Member of the Royal Society of Chemistry, London, MASAA Innovation Pvt. Ltd. stands as an example of how visionary science can be translated into real-world applications that benefit society at large. Mrs. Swati Mazumder, Director, plays a key role in strategic communication, media engagement, and organizational development, strengthening the company’s outreach and brand presence.
At AMSAACARE, our vision is to develop innovative, safe, and scientifically validated products that protect human life and health, while addressing some of the most critical challenges in hygiene, infection control, and disease management.
We aim to bridge the gap between advanced laboratory research and everyday consumer and medical needs, ensuring that innovation reaches people in forms that are accessible, effective, and affordable.
The scientific journey behind AMSAACARE began long before the company’s incorporation. Professor Amitava Mazumder initiated his invention process as early as 2010, collaborating with and outsourcing work to various leading laboratories across India. These early efforts laid the foundation for a decade-long research program rooted in deep-driven chemistry, biochemistry, microbiology, virology, oncology, and drug-target interaction studies.
In 2019, the research was formally incubated at ASPIRE-BioNEST, University of Hyderabad, marking a major milestone in structured innovation and validation. Over the years, extensive investigations were conducted through premier Indian institutions including ICMR laboratories, CSIR, CCMB, BTL, DRDE, IICT, IPC, and several other reputed organizations. These studies focused on efficacy validation, chemical characterization, stability testing, and safety profiling.
At AMSAACARE, safety and compliance are non-negotiable. Our products and formulations have undergone OECD-compliant safety studies, conducted through top-tier GLP-certified Contract Research Organizations (CROs). This includes human skin trial studies, ensuring that our FMCG and healthcare products meet the highest standards of safety and reliability.
Our antimicrobial formulations have achieved DCGI licenses as new drug formulations, particularly for applications on inanimate surfaces and high-pathogenic environments. These approvals underline the scientific robustness and regulatory acceptance of our innovations.
AMSAACARE has successfully translated advanced antimicrobial science into a strong FMCG product portfolio, with sales initiated across multiple states in India. Our ready FMCG products are designed to deliver everyday protection backed by science, catering to households, institutions, and high-risk environments.
AMSAA Fog – Advanced antimicrobial fogging solution
Flowsafe Sanitary Pads – Designed to Keep Safe from Germs
AMSAA Diapers – Adult and Baby care solutions
AMSAA Wet Wipes – Antimicrobial personal hygiene wipes
AMSAA Toilet Cleaner – Powerful and safe surface disinfectant
AMSAA Humidifier Liquid – Hygienic air-care solution
AMSAA Mouth Fresheners – Oral hygiene and freshness
AMSAA Antiseptic – Skin-safe antimicrobial solution
AMSAA Aftershave – Hygiene-focused grooming product
Each product is developed with a focus on efficacy, safety, and user comfort, supported by scientific validation rather than marketing claims alone.
AMSAACARE is actively advancing a strong pharmaceutical pipeline focused on addressing critical and life-threatening diseases through novel intravenous drug formulations. Our upcoming medicinal products are developed through deep scientific research, validated mechanisms of action, and global regulatory alignment. These innovations are protected through UK patent filings, with a Novel Drug Formulation patent already granted, reinforcing our commitment to originality, safety, and global healthcare impact.
Professor Amitava Mazumder holds multiple granted and applied patents in India, the USA, and the UK. His innovations have received highly positive evaluations from WIPO, with comments recognizing them as entirely novel and of immense human applicability.
These inventions not only advance healthcare solutions but also contribute to India’s global standing in innovation and scientific research. The contributions made through this work have supported India’s improved ranking in global innovation indices.
Parallel to human healthcare applications, AMSAACARE has developed an Organic Colloidal Antimicrobial Sol designed for industrial applications. This innovation extends antimicrobial protection to various industrial environments, enhancing hygiene, safety, and operational efficiency across sectors.
AMSAACARE operates with a focused and agile research team, hand-picked to support specialized scientific investigations. The company thrives on collaboration, integrity, and intellectual rigor. Media, communication, and outreach efforts are led by Mrs. Swati Mazumder, supported by trusted professionals who have stood by the organization through its long research journey.
At AMSAACARE, we believe that science must serve humanity. Every product, every formulation, and every research initiative is driven by a single commitment:
to protect lives through innovation, responsibility, and uncompromising scientific excellence.
We continue to move forward with confidence, guided by vision, validated by science, and inspired by the promise of a healthier future.